Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium

[1]  Haotian Lin,et al.  Increasing lymphatic microvessel density in primary pterygia. , 2012, Archives of ophthalmology.

[2]  D. Ribatti,et al.  Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and Prox-1 in human pterygium. , 2011, Oncology reports.

[3]  J. Ambati,et al.  Soluble VEGFR‐2: an antilymphangiogenic variant of VEGF receptors , 2010, Annals of the New York Academy of Sciences.

[4]  J. Ambati,et al.  Neuroblastoma Progression Correlates with Downregulation of the Lymphangiogenesis Inhibitor sVEGFR-2 , 2010, Clinical Cancer Research.

[5]  D. Carr,et al.  VEGF-A expression by HSV-1–infected cells drives corneal lymphangiogenesis , 2009, The Journal of experimental medicine.

[6]  D. Miyazaki,et al.  Role of periostin and interleukin-4 in recurrence of pterygia. , 2010, Investigative ophthalmology & visual science.

[7]  S. Wiegand,et al.  Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation , 2009, The Journal of Immunology.

[8]  Shiqi Ling,et al.  Crucial role of corneal lymphangiogenesis for allograft rejection in alkali‐burned cornea bed , 2009, Clinical & experimental ophthalmology.

[9]  M. Detmar,et al.  Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis. , 2009, The Journal of investigative dermatology.

[10]  R. Dana,et al.  Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation , 2009, British Journal of Ophthalmology.

[11]  R. Dana,et al.  Corneal Lymphangiogenesis: Implications in Immunity , 2009, Seminars in ophthalmology.

[12]  M. Detmar,et al.  The lymphatic system in health and disease. , 2008, Lymphatic research and biology.

[13]  H. Okano,et al.  Epithelial-mesenchymal transition in the pathogenesis of pterygium , 2008 .

[14]  C. Cursiefen,et al.  Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  E. Crivellato,et al.  Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium , 2007, Journal of cellular and molecular medicine.

[16]  H. Okano,et al.  Β-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium , 2007 .

[17]  Shuji Takahashi,et al.  Immunolocalisation of E-cadherin and &bgr;-catenin in human pterygium , 2007, British Journal of Ophthalmology.

[18]  M. Dana,et al.  Vascular Endothelial Growth Factor Receptor-3 Mediates Induction of Corneal Alloimmunity , 2007, Ocular immunology and inflammation.

[19]  S. Hirakawa,et al.  Vascular endothelial growth factor-A mediates ultraviolet B-induced impairment of lymphatic vessel function. , 2006, The American journal of pathology.

[20]  D. Stephan,et al.  Microarray and protein analysis of human pterygium. , 2006, Molecular vision.

[21]  Yihai Cao,et al.  Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Maruyama,et al.  Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. , 2005, The Journal of clinical investigation.

[23]  Toshio Ohhashi,et al.  PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. , 2004, Cancer cell.

[24]  M. Dana,et al.  Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity , 2004, Nature Medicine.

[25]  Jingtai Cao,et al.  VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. , 2004, The Journal of clinical investigation.

[26]  D. Wakefield,et al.  Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases , 2004, Progress in Retinal and Eye Research.

[27]  Claus Cursiefen,et al.  Corneal Lymphangiogenesis: Evidence, Mechanisms, and Implications for Corneal Transplant Immunology , 2003, Cornea.

[28]  D. Wakefield,et al.  The role of ultraviolet irradiation and heparin-binding epidermal growth factor-like growth factor in the pathogenesis of pterygium. , 2003, The American journal of pathology.

[29]  M. Orhan,et al.  The roles of T-lymphocyte subpopulations (CD4 and CD8), intercellular adhesion molecule-1 (ICAM-1), HLA-DR receptor, and mast cells in etiopathogenesis of pterygium , 2003, Ocular immunology and inflammation.

[30]  Rakesh K. Kumar,et al.  UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. , 2002, Investigative ophthalmology & visual science.

[31]  E. Tsironi,et al.  HLA-DR antigen expression in pterygium epithelial cells and lymphocyte subpopulations: an immunohistochemistry study. , 1995, German journal of ophthalmology.

[32]  L. Liu,et al.  Immunological studies on the pathogenesis of pterygium. , 1993, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[33]  A. Solomon.  Immunologic basis for the pathogenesis of pterygium. , 1985, American journal of ophthalmology.